Zeenea helps pharmaceutical companies get the most value out of their existing data assets. Leverage our data discovery platform to:
- Initiate a data-driven strategy
- Strike the right balance between defensive and offensive data governance
- Guarantee the conformity of your drug production regarding pharma-specific regulations
- Accelerate patient data analysis to identify new trends & market opportunities
- Get a return on your data investments.
Zeenea use cases in the Pharmaceutical Industry
Comply with various regulations
Accelerate Drug Data Discovery
Increase Clinical Trial efficacy
Optimize Drug Utilization
Improve safety and risk management
How Zeenea Unlocks Data for the Pharmaceutical Industry
Our universal connectivity and API-first approach allows Zeenea to adapt to any system, and to any data strategy (edge, cloud, multi-cloud, cross-cloud, hybrid) to build an enterprise-wide information repository.
We provide the most comprehensive connectivity of the market with the ability to automate metadata curation with our wide range of connectors.
Our platform provides modular metamodel templates that enable banks and insurance companies to quickly and incrementally build easy-to-use and comprehensive models to serve business needs and regulatory reports.
Structure your assets’ documentation with simple “drag & drop” features and create documentation templates for each type of asset in the way that works best for you.
Zeenea automates data lineage by gathering data processes and data asset transformations from ETL platforms and data pipelines, or from manual descriptions for compliance and regulation.
Our solution also provides an audit trail for any action done in the data catalog.
Both of our applications provide all your data consumers with sharing capabilities to allocate their knowledge on various objects in the catalog through collaborative features.
Thus, interactions between teams and experts will be simplified and the aggregation of knowledge acquired during use cases will finally be possible.
How does a Data Catalog unlock business value for the Pharmaceutical industry?